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Introduction 20
Autophagy is a bulk degradation system, which controls the clearance and reuse of 21 intracellular constituents, and is important for the maintenance of an amino acid pool essential 22 for survival [1] [2] [3] . Autophagy can be activated by nutritional deprivation and intracellular 23 stress, such as hypoxia. Genetic studies in yeast have identified many autophagy-related (Atg) 24 genes that are required for autophagosome formation essential for autophagy, such as Atg3, 25
Atg5, Atg7, Atg9a, and Atg16L1 [4]. Most of the Atg genes are conserved in higher eukaryotes. 26
In yeast, autophagy-defective mutants were unable to survive under conditions of nitrogen 27 starvation [5] . Similarly, the Atg3-, Atg5-, Atg7-, Atg9a-, and Atg16L1-knockout mice 28 (genotypes of each Atg -/-) did not survive, and usually died within one day after birth [6] [7] [8] [9] . 29 Thus, autophagy was found to be crucial for survival in the neonatal period [6-10], while mice 30 heterozygous for the knockout allele of the Atg9a gene (Atg9a +/-) grew normally [9] . Even in 31 the embryonic stages, a shortage of nutrient and oxygen supply from the placenta occurs in 32 human fetuses in certain clinical conditions, such as hypertensive pregnancies and maternal 33 malnutrition, leading to fetal growth restriction (FGR) and intrauterine fetal death (IUFD) 34 [11] [12] [13] . Therefore, similar adverse events may occur in response to unfavorable intrauterine 35 environments in fetal mice devoid of autophagic machinery. Indeed, FGR and IUFD have 36 been reported in fetal mice deficient in beclin 1, which is another gene essential for autophagy 37 [14] . 38
The Atg9b gene -expressed in the placenta -functionally complements Atg9a [19] . 39 Therefore, Atg9b protein expression may be higher in the placenta of Atg9a -/fetal mice. 40 When the expression of Atg9b protein is increased, autophagic activity may be monitored by 41 quantifying the expression of LC3-II (truncated protein of LC3-I) in the placenta of Atg9a -/-42 fetal mice. 43
The p57 Kip2 , a potent inhibitor of the cyclin-cyclin dependent kinase (CDK) 44 complex, is a paternally imprinted gene located within a cluster of imprinted genes in humans 45 (chromosome 11p15.5) and mice (distal chromosome 7) [15, 16] . As p57 Kip2+/-(heterozygous, 46 lacking the paternal allele) pregnant mice develop abnormalities similar to preeclampsia, 47 including hypertension and proteinuria when carrying a fetus without p57 Kip2 expression [17], 48 these mice can be used as an animal model for hypertensive disorders in pregnancy. The 49 present study was performed to determine whether fetal Atg9a is involved in survival and in 50 utero growth in pregnant mice heterozygous for Atg9a (Atg9a +/-) with and without p57 Kip2+/-. 51 4 lacking the imprinted paternal allele (p57 Kip2+/-) [18], were provided by co-authors (KN and 62 KN). In the current study, female mice of Atg9a +/alone were mated with male mice of 63 p57 Kip2 +/to generate female mice heterozygous for knockout alleles of Atg9a and p57 Kip2 64 (Atg9a +/-/p57 Kip2 +/-). The genotype of generated Atg9a +/-/p57 Kip2 +/female was determined 65 by PCR of tail DNA. Female mice of Atg9a +/and Atg9a +/-/p57 Kip2 +/were mated with male 66 mice of Atg9a +/to generate four embryo groups (groups A1, A2, B1 and B2, Tab. 1) divided 67 according to differences in mother and fetal Atg9a genotypes. Pregnancy stage was expressed 68 as the number of days post coitum (dpc). Thirteen pregnant mice with Atg9a +/and 13 69 pregnant mice with Atg9a +/-/p57 Kip2 +/were used in the study. Pregnant mice of both groups 70 were sacrificed on 13.5, 15.5, and 17.5 dpc for determination of the number of fetuses, 71 measurement of live fetal body weight and determination of fetal Atg9a genotypes by PCR of 72 tail DNA ( Fig. 1) . 73 74
Measurement of blood pressure in pregnant mice 75
Blood pressure was measured with a tail-cuff using a CODA™ monitor (Kent Scientific, 76
Torrington, CT, USA), 5 -10 times at 30 s intervals, 15 min after the behavior and heart rate 77 of the pregnant mice were stabilized in the morning of 5.5, 9.5, 13.5, 15.5, and 17.5 dpc. 78
Blood pressure values are reported as the means of at least three measurements varying by 5% 79 obtained in one session. 80 81 82
Measurement of fetal body weight 83
The body weights of pregnant mice and alive fetal mice were measured using Electronic 84 balance FA-200 (A&D, Tokyo, Japan). Pregnant mice were anesthetized deeply with ether 85 and dissected in the lower abdomen. The multilocular uterus containing a fetus in each 86 loculus was incised and fetuses with their placentas were separated from the uterus. Some 87 fetuses, based on their color and size, appeared to be dead at sacrifice. Fetuses that were less 88 pinkish and smaller than others were judged as dead ( Fig. 1; upper panel) . These fetuses were 89 subjected to Atg9a genotype determination, but their body weights were not measured. 90 91
DNA extraction, PCR amplification and electrophoresis 92
The Atg9a genotypes of the fetuses ( for Atg9a, 2 min at 50°C, 10 s at 95°C, 40 cycles at 95°C for 15 s and 59°C for 1 min; and for 7 5'-GCATCACATCCAGAACCTGGA-3' (forward) and 124 5'-CCGCTGATGATAGCTGTAGATCTTG-3' (reverse) for Atg9b, and 125 5'-GGCATTGCTCTCAATGACAA-3' (forward) and 5'-TGTGAGGGAGATGCTCAGTG-3' 126 (reverse) for GAPDH. 127 systolic blood pressure (SBP) during pregnancy (Fig. 2) , while Atg9a +/-/p57 Kip2 +/mice (used 166 to obtain B1 and B2 groups, Tab. 1) exhibited a significant increase in SBP at 9.5 dpc (113 ± 167 11.6 mm Hg) and thereafter (116 ± 12.6, 125 ± 16.2, and 121 ± 12.8 mm Hg for 13.5, 15.5, 168 and 17.5 dpc, respectively) compared to SBP baseline (102 ± 12.0 mm Hg) determined before 169 pregnancy. The SBP differed significantly between the two groups (A vs. B) at 9.5 dpc (113 ± 170 11.6 vs. 99 ± 9.5 mm Hg), 15.5 dpc (125 ± 16.2 vs. 95 ± 10.5 mm Hg), and 17.5 dpc (121 ± 171 12.8 vs. 102 ± 12.1 mm Hg). Pre-pregnancy body weight did not differ significantly between 172 female mice of Atg9a +/-(normotensive pregnancy [A] group; n=13; Tab. 1) and Atg9a 173 +/-/p57 Kip2 +/-(hypertensive pregnancy group [B]; n=13) groups (22.8 ± 2.7 vs. 21.7 ± 2.5 g, 174 respectively). 175
The expression of Atg9a mRNA was significantly reduced in Atg9a -/placentas 176 compared to Atg9a +/and Atg9a +/+ placentas (Fig. 3) . Then, placental expression of Atg9b The fetal body weight was significantly lower in fetuses carried by hypertensive 193 dams than those of normotensive dams (B1 and B2 < A1 and A2) at all stages of pregnancy 194 ( Fig. 5 ). The fetal body weight was also significantly lower in Atg9a -/fetal mice (groups A2+ 195 B2) than in Atg9a +/+ and Atg9a +/fetal mice (groups A1 +B1) on 13.5 and 17.5 dpc (Fig. 6) . 196
Finally, the body weight of fetuses carried by hypertensive dams was usually lower than that 197 fetuses of normotensive dams (Fig. 7) . At any stage of pregnancy, fetal body weight did not 198 differ between the groups carried by normotensive dams (A1 vs. A2). In contrast, body weight 199 of fetuses carried by hypertensive dams was significantly lower in group B2 than in group B1 200 on 15.5 and 17.5 dpc (Fig. 7) . 201 202
Discussion 203
The current study demonstrated that the growth of Atg9a -/fetal mice was retarded compared 204 with Atg9a +/+ and Atg9a +/fetal mice. This confirmed the results of previous studies in which 205 autophagy-defective fetal mice devoid of Atg genes other than Atg9a were born with lower 206 birth weight than those with normal (in relation to autophagy) phenotype [6,7,10]. In addition, 207 it was suggested that Atg9a-knockout fetal mice are characterized by an increased likelihood 208 of dying in utero, as it was reported for beclin 1-knockout fetal mice [14] . 209
Since in mice autophagy remains at a low level throughout the embryonic period 210 and massive autophagy occurs transiently soon after birth in normal neonatal mice, autophagy 211 was suggested to play minor role in fetal mouse development [6] . Therefore, fetal growth 212 restriction of Atg9a-knockout fetal mice has not been emphasized in previous reports [6,7,10]. 213
The body weights of Atg3 -/-, Atg5 -/-, and Atg7 -/neonatal mice were significantly lower 214 than those of wild-type and heterozygous mice [6,7,10]. As all Atg3 -/-, Atg5 -/-, Atg7 -/-, and 215
Atg9a -/mice are indeed defective in autophagy [6,7,9,10], these results suggest that the lack 216 of functional autophagic machinery in fetuses resulted in a lower birth weight. Thus, the fetal 217 autophagic machinery has a protective function against FGR. This notion was further 218 supported by our findings that FGR was observed in Atg9a -/fetal mice carried by 219 hypertensive dams. 220
Although in the current study, the fetus size in normotensive dams did not differ 221 significantly among different fetal Atg9a genotype, the Atg9b and LC3-II proteins were 222 present in the placentas of Atg9a -/fetal mice. The placental autophagy may have prevented 223 FGR in Atg9a -/fetal mice carried by normotensive dams. The deleterious effect of 224 hypertension in addition to the lack of fetal autophagy, in turn, may have outweighed the 225 protective effect of placental autophagy on FGR in fetuses carried by hypertensive dams.
causing FGR and IUFD in humans [12] . Placental insufficiency due to poor blood supply via 228 the uterine arteries is the most common cause of fetal starvation, and the increased impedance 229 to flow within uterine arteries occurs frequently in hypertensive disorders in pregnancy 230 [11, 13] . In such an unfavorable intrauterine environment, fetal autophagy may be activated, 231 and placental autophagy was indeed increased in women with hypertensive disorders and/or 232 FGR [20-24]. In addition, the expression of LC3-II protein in the human placenta tended to 233 linearly increase with a decreasing normalized infant birth weight [24] . The findings in 234 humans and mice suggest that dysfunction of the fetal autophagic machinery is causally 235 associated with FGR, and an unfavorable intrauterine environment such as maternal 236 hypertension outweighs the protective role of fetal autophagy in FGR, leading to FGR even 237 after the activation of autophagy. 238
The Atg9a -/fetal mice had a high likelihood of in utero death in the present study. 239
In addition, the frequency of Atg9a -/fetal mice was somewhat lower than the expected 240 Mendelian frequency, even after including dead fetuses. Similar findings, but with a more 241 severe phenotype, were reported in beclin 1-knockout fetal mice. No homozygous mutant 242 offspring (beclin 1 -/-) were born to dams heterozygous for beclin 1 because all beclin 1 -/-243 fetal mice had severely retarded growth and died in the early embryonic stages [14] . Such 244 early-dead fetuses become conceptus traces and are not recognized as fetuses [14] . These 245 early embryonic deaths may help to explain why less Atg9a -/fetal mice than expected were 246 observed in the current study. In addition, strict classification of fetal mice as dead or alive 247 was not easy and was based on color and size. Therefore, some fetal mice classified as dead 13 might have been alive. 249
In conclusion, in the current study we have focused on the examination of the 250 effects of Atg9a deficiency in fetal mice on fetal growth and survival. We demonstrated that 251
Atg9a-knockout (Atg9a -/-) fetal mice were likely to show growth restriction, especially in the 252 presence of maternal hypertension. This suggests that dysfunction of fetal autophagic 253 machinery causes lower fetal body weight. In addition, the results of the study indicated that 254 fetal mice devoid of Atg9a had an increased likelihood of dying in utero, similar to the 255 observations reported previously for autophagy-defective beclin 1 -/mice [14] . 
